🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Philips cuts outlook as China demand slumps, shares tumble 17%

Published 10/28/2024, 03:24 AM
Updated 10/28/2024, 06:08 AM
© Reuters.
PHG
-

Investing.com -- Philips (AS:PHG) reported third-quarter results that posted a revenue miss and a revised outlook, primarily due to weaker demand in China.

Revenues missed consensus by 3%, and order intake fell by 2% after a strong prior quarter. While adjusted EBITA was in line with expectations, analysts at UBS said that this figure was boosted by unusually high royalty income.

Without this benefit, the adjusted EBITA would have missed by 8%. The overall revenue shortfall has raised concerns about Philips' growth, with management revising its full-year revenue growth forecast downward from an anticipated 3%-5% to a range of 0.5-1.5%.

This revision reflects heightened uncertainties, particularly in China, where demand challenges have deepened.

UBS analysts flagged underperformance across several Philips segments. Diagnosis & Treatment sales were 3% below consensus, showing only a 1% organic fall, which fell short of the expected 2% growth.

Connected Care sales and Personal Health both trailed expectations, missing forecasts by 3% and 7%, respectively, and each recorded no organic growth or declines compared to anticipated increases.

UBS noted that even with a favorable income boost from royalties, underlying profitability remains under strain.

Management's guidance cut and the broader revenue miss have weighed on investor sentiment, with UBS analysts suggesting this could lead to further scrutiny, especially given the company's disappointing order intake following an already soft comparison period last year.

“We believe there had been some hopes for a margin guidance raise, but instead we’re likely to get 2-3% cuts to sales and adj EBITA. We see the shares off MSD, maybe a little more,” said analysts at J.P. Morgan in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.